Skip to main content

Table 2 Items of study questionnaire related to pharmacy switch

From: Pharmacy switch of antipsychotic medications: patient’s perspective

Introduction

 

 The questions refer to your visits in pharmacy over the last 12 months with a prescription for antipsychotic medications received from your doctor

 

Questions and explanations to patients

Responses and its analyses

1. Were you offered by a pharmacist an antipsychotic medication named differently from that prescribed by your doctor?

Quantitative analysis of yes/no responses

If yes, please, refer to the most recent or most remembered visit and answer the following questions. If no, please, do not answer the other questionsa

 

2. Did you receive any explanations from a pharmacist proposing the switch of the antipsychotic medication prescribed by your doctor?

Quantitative analysis of yes/no responses

3. Did you accept this proposal?b

Quantitative analysis of yes/no responses

4. What was your attitude to this situation?

Quantitative analysis of responses on the Likert-like scale

Very negative

Negative

Neutral

Positive

Very positive

5. What was your emotional response to this situation?

Qualitative analysis of patient’s descriptions

6. Did you inform your psychiatrist about this situation?

Quantitative analysis of responses

No

Yes, during an unscheduled visit

Yes, during a scheduled visit

7. Did you notice any subjective changes in drug’s efficacy and/or tolerance after the switch?c

Quantitative analysis of yes/no responses

If “yes”, qualitative analysis of patient’s reports

8. Did you change a dose or frequency of antipsychotic drug administration after the switch?c

Quantitative analysis of yes/no responses

If “yes”, qualitative analysis of patient’s reports

  1. aQuestion 1: 99 of 196 patients answered “yes”, 97 of 196 patients answered “no” and were not asked questions 2–8
  2. bQuestion 3: 75 of 99 patients answered “yes” (“acceptors”), 24 of 99 patients answered “no” (“non-acceptors”)
  3. cQuestions 7–8: administered only to 75 of 99 patients who accepted the proposal of medication switch (“acceptors”)